Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Clinical trial NCT00573521 · COMPLETED

Trial details

NCT number: NCT00573521
Sponsor: University of Pittsburgh
Status: COMPLETED
Study type: OBSERVATIONAL

Enterobacteriaceae Infections

Start date: 2007-11-01
Primary completion: 2017-06-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.